Literature DB >> 21229992

Detailed mechanism of squalene epoxidase inhibition by terbinafine.

Marcin Nowosielski1, Marcin Hoffmann, Lucjan S Wyrwicz, Piotr Stepniak, Dariusz M Plewczynski, Michal Lazniewski, Krzysztof Ginalski, Leszek Rychlewski.   

Abstract

Squalene epoxidase (SE) is a key flavin adenine dinucleotide (FAD)-dependent enzyme of ergosterol and cholesterol biosynthetic pathways and an attractive potential target for drugs used to inhibit the growth of pathogenic fungi or to lower cholesterol level. Although many studies on allylamine drugs activity have been published during the last 30 years, up until now no detailed mechanism of the squalene epoxidase inhibition has been presented. Our study brings such a model at atomic resolution in the case of yeast Saccharomyces cerevisiae . Presented data resulting from modeling studies are in excellent agreement with experimental findings. A fully atomic three-dimensional (3D) model of squalene epoxidase (EC 1.14.99.7) from S. cerevisiae was built with the help of 3D-Jury approach and further screened based on data known from mutation experiments leading to terbinafine resistance. Docking studies followed by molecular dynamics simulations and quantum interaction energy calculations [MP2/6-31G(d)] resulted in the identification of the terbinafine-squalene epoxidase mode of interaction. In the energetically most likely orientation of terbinafine its interaction energy with the protein is ca. 120 kJ/mol. In the favorable position the terbinafine lipophilic moiety is located vertically inside the squalene epoxidase binding pocket with the tert-butyl group oriented toward its center. Such a position results in the SE conformational changes and prevents the natural substrate from being able to bind to the enzyme's active site. That would explain the noncompetitive manner of SE inhibition. We found that the strongest interaction between terbinafine and SE stems from hydrogen bonding between hydrogen-bond donors, hydroxyl group of Tyr90 and amine nitrogen atom of terbinafine. Moreover, strong attractive interactions were recorded for amino acids whose mutations resulted in terbinafine resistance. Our results, elucidating at a molecular level the mode of terbinafine inhibitory activity, can be utilized in designing more potent or selective antifungal drugs or even medicines lowering cholesterol in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21229992     DOI: 10.1021/ci100403b

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  23 in total

1.  CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches.

Authors:  Mary A Davis; Dustyn A Barnette; Noah R Flynn; Anirudh S Pidugu; S Joshua Swamidass; Gunnar Boysen; Grover P Miller
Journal:  Chem Res Toxicol       Date:  2019-04-10       Impact factor: 3.739

Review 2.  Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome.

Authors:  Aleksey Porollo; Jaroslaw Meller; Yogesh Joshi; Vikash Jaiswal; A George Smulian; Melanie T Cushion
Journal:  Curr Drug Targets       Date:  2012-11       Impact factor: 3.465

Review 3.  The Future of Antifungal Drug Therapy: Novel Compounds and Targets.

Authors:  Caroline Mota Fernandes; Deveney Dasilva; Krupanandan Haranahalli; J Brian McCarthy; John Mallamo; Iwao Ojima; Maurizio Del Poeta
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

4.  Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors.

Authors:  Yunfei An; Yue Dong; Liu Min; Liyu Zhao; Dongmei Zhao; Jun Han; Bin Sun
Journal:  ACS Med Chem Lett       Date:  2020-05-11       Impact factor: 4.345

5.  Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.

Authors:  Shivaprakash M Rudramurthy; Shamanth A Shankarnarayan; Sunil Dogra; Dipika Shaw; Khurram Mushtaq; Raees A Paul; Tarun Narang; Arunaloke Chakrabarti
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

6.  In Silico Analog Design for Terbinafine Against Trichophyton rubrum: A Preliminary Study.

Authors:  Sudha Karumuri; Puneet Kumar Singh; Pratyoosh Shukla
Journal:  Indian J Microbiol       Date:  2015-04-01       Impact factor: 2.461

7.  Terbinafine Resistance of Trichophyton Clinical Isolates Caused by Specific Point Mutations in the Squalene Epoxidase Gene.

Authors:  Tsuyoshi Yamada; Mari Maeda; Mohamed Mahdi Alshahni; Reiko Tanaka; Takashi Yaguchi; Olympia Bontems; Karine Salamin; Marina Fratti; Michel Monod
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

8.  Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection.

Authors:  Ditte M L Saunte; Rasmus K Hare; Karin M Jørgensen; René Jørgensen; Mette Deleuran; Claus O Zachariae; Simon F Thomsen; Lars Bjørnskov-Halkier; Kristian Kofoed; Maiken C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

9.  Potential anti-alopecia constituents from Theobroma cacao: An in silico study.

Authors:  Dikdik Kurnia; Faruk Jayanto Kelutur; Resmi Mustarichie
Journal:  J Adv Pharm Technol Res       Date:  2021-04-27

Review 10.  Interactions with Microbial Proteins Driving the Antibacterial Activity of Flavonoids.

Authors:  Giuliana Donadio; Francesca Mensitieri; Valentina Santoro; Valentina Parisi; Maria Laura Bellone; Nunziatina De Tommasi; Viviana Izzo; Fabrizio Dal Piaz
Journal:  Pharmaceutics       Date:  2021-05-05       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.